TyRx

About:

TYRX delivers site-specific therapy by commercializing medical-pharmaceutical combination devices for multiple surgical markets.

Website: http://www.tyrx.com

Twitter/X: aigisrx

Top Investors: HLM Venture Partners, Clarus Ventures, Pappas Ventures, MemorialCare Innovation Fund

Description:

TyRx engages in the design, development, and commercialization of resorbable polymeric biomaterials. It offers PIVIT CRM, a mesh based pouch, which contains antibacterial agents to help provide protection from microbial colonization of the generator or defibrillator during and immediately after surgical implant. The company also provides AIGISRx Flat, an antibacterial product that provides protection against infections associated with implanted pacemakers and defibrillators. TyRx Pharma, Inc. was formerly known as Advanced Materials Design, LLC. The company was founded in 1997 and is based in Monmouth Junction, New Jersey.